Study of the natural course of spinal muscular atrophy
Part of Brain & nervous system clinical trials.
This study observes how spinal muscular atrophy changes over time without giving an investigational treatment. It may help researchers learn what to expect in the disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a patient with spinal muscular atrophy (SMA).
- Not currently enrolled in another clinical trial.
- You may be asked to share medical history and follow-up information over time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with spinal muscular atrophy (SMA) who have a particular genetic change in the SMN1 gene. It compares long-term outcomes for those who do and do not receive disease-modifying treatments, to better understand what helps over time.
This study watches how people with certain muscle or nerve diseases walk over time. It may help doctors understand changes in walking patterns and is open to adults who can walk and have a genetic diagnosis of a neuromuscular condition.
This is a long-term observation study that follows people affected by spinal muscular atrophy (SMA), people who carry the SMA gene but have no symptoms, and families of people with SMA. It helps researchers better understand SMA and related genetic status, which can support future treatment planning.
This study collects health information from people with spinal muscular atrophy (SMA) over time to learn more about the disease and how to improve care. It may help researchers understand SMA better.
This trial is a registry that collects health information from people with spinal muscular atrophy (SMA). It helps researchers understand the condition better and may support future studies and treatments.
This study is looking for children and teens with spinal muscular atrophy (SMA) who are already on a treatment like Spinraza, Evrysdi, or Zolgensma. The goal is to understand different forms of SMA and how the treatment affects them over time.
Hear when a new Muscular Atrophy, Spinal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.